The AMA’s report, released Sept. 9, found that CVS Health, OptumRx, Express Scripts and Prime Therapeutics control 70% of the national PBM market, according to a news release shared with Becker’s. The analysis also found that 82% of PBM markets at the regional level are highly concentrated, suggesting limited competition.
The AMA highlighted concerns over limited competition and high levels of vertical integration of PBMs with health insurance companies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
